Combination Therapy in Systemic Mycosis

References

• Polak A. Combined therapy of systemic mycoses. Proc 13th Intern Congr Chemother Vienna 1983. Spitzy KH, Karrer K (eds.) Symposia 49/1 and 49/2, part 20 Vienna: H Egermann, 2–9.
   Google Scholar
• Polak A. Combination therapy with antifungal drugs. Mycoses 1988; 31 Suppl 2: 45–53.
   Google Scholar
• Polak A. Combination therapy for systemic mycosis. Infection 1989; 17 (4): 203–208.
   Google Scholar
• Polak A. Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice. Chemotherapy 1987; 33: 381–395.
   Google Scholar
• Polak A, Scholer HJ, Wall M. Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice. Chemotherapy 1982; 28: 461–479.
   Google Scholar
• Thaler M, Bacher J, O'Leary T. Evaluation of single-drug and combination antifungal therapy in an experimental model of candidiasis in rabbits with prolonged neutropenia. J Infect Dis 1988; 158 (1): 80–88.
   Google Scholar
• Hughes CE, Peterson LR, Beggs WH, Gerding DN. Ketoconazole and flucytosine alone and in combination against Candida spp. in a neutropenic site in rabbits. J Anti-microb Chemother 1986; 18: 65–72.
   Google Scholar
• Walsh TJ, Aoki S. Mechinaud F, Foulds G, Rubin M, Pizzo PA. Fluconazole in the treatment of disseminated candidiasis in persistently granulocytopenic rabbits. Microbiology 1988; 406: Abstract F-88.
   Google Scholar
• Schaffner A, Frick PG. The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis. J Infect Dis 1985; 151 (5): 902–920.
   Google Scholar
• Bennet JE, Dismukes WE, Duma RJ et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med 1979; 301 (3): 127–131.
   Google Scholar
• Dismukes WE, Cloud G, Gallis HA et al. Treatment of crytococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med 1987; 317 (6): 334–341.
   Google Scholar
• Kauffmann CA, Frame PT. Bone marrow toxicity associated with 5-fluorocytosine therapy. Antimicrob Agents Chemother 1977; 11 (2): 244–247.
   Google Scholar
• Heidemann H, Krich W, Gerkens J, Branch R. Salzbeladung verringert Amphotericin B - induzierte Nephrotoxität. Verh Ges inn Med. 1983; 89: 921–922.
   Google Scholar
• Heidemann H, Jacqz E, Ohnhaus E, Ray W, Branch R. The importance of Na loading on amphotericin B nephrotoxicity considering the combination with 5-fluorocytosine and ticarcillin. Recent Advances in Chemotherapy. Antimicr Section 3 (Proc 14th Int Congr Chemother Kyoto 1985); 2628–2629.
   Google Scholar
• Mayer RD, Holmberg K. Fungal infections in HIV - infected patients. In: Holmberg K and Meyer RD (ed): Diagnosis and Therapy of Systemic Fungal Infections. New York: Raven Press. 1989: 79–100.
   Google Scholar
• Chernoff DN, Sande MA. Cryptococcal infections in patients with the Acquired Immunodeficiency Syndrome (AIDS). Paper presented at the Conférence Internationale sur le SIDA, 23–25 June 1986; Paris Abstr No. 543.
   Google Scholar
• Staib F, Roegler G, Fruefer-Kraemer L, Seibold M, Eichenlaub D, Pohle HD. Disseminierte Kryptokokkose bei zwel AIDS-Patienten. Dtsch Med Wochenschr 1986; 111: 1061–1065.
   Google Scholar
• Larsen RA, Bozzette S, McCutchan JA, Chiu J, Leal MA, Richmann DD, and the California Collaborative Treatment Group. Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. Ann Int Med 1989; 111 (2): 125–28.
   Google Scholar
• Dismukes W, Cloud G, Thompson S et al. Fluconazole (FLU) versus Amphotericin B (AMB) therapy (Rx) of acute cryptococcal meningitis (CM.). 29th ICAAC, Houston, 1989, Abstract No. 1065.
   Google Scholar
• Dismukes W. Combination therapy with amphotericin B and flucytosine for selected systemic mycoses. In: Holmberg K and Meyer RD (ed): Diagnosis and Therapy of Systemic Fungal Infections. New York: Raven Press. 1989: 121–132.
   Google Scholar
• Larsen RA, Leal ME. Fluconazole compared to amphotericin B as treatment of cryptococcal meningitis. 29th ICAAC, Houston, 1989, Abstract No. 1062.
   Google Scholar
• Floch JJ, LaRoche R, Deppner MD, Kadende P, Saunière JF. Résultats préliminaires du traitement des méningoencéphalites à C neoformans au Burundi (à propos de 50 cas). Int Conf on AIDS. The Scientific and Social Challenge. 1989, Abstract B 599.
   Google Scholar
• Kahotwa M, Kapita B, Colebunders B, Mungierei A, Perriens J. Efficacité du fluconazole comparé avec amphotericine B plus 5-flucytosine dans le traitement intensif et de maintien de la cryptococcose meningé associée au SIDA. Int Conf on AIDS. The Scientific and Social Challenge. 1989, Abstract WBP 12.
   Google Scholar
• Sugar AM Sander D. Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with Acquired Immunodeficiency Syndrome. Am J Med 1988; 85: 481–489.
   Google Scholar
• Viviani MA, Tortorano AM, Antonio P et al. European experience with itraconazole in systemic mycoses. J Am Acad Dermatol (in press).
   Google Scholar
• Viviani MA, Tortorano AM, Woenstenborghs R, Cauwenbergh G. Experience with itraconazole in deep mycoses in northern Italy. Mykosen 1988; 30: 233–244.
   Google Scholar
• Tozzi V, Bordi E, Galgani S, Leoni GC, Narciso P, Sette P, Visco G. Fluconazole treatment of cryptococcosis in patients with acquired immunodeficiency syndrome. Am J Med 1989; 87 (3): 353.
   Google Scholar
• Nelson KE, Thaker GK, Merz W, Bartlett JG. Response of cryptococcal meningitis to antifungal therapy in patients with EIDS. V Int Conf on AIDS. The Scientific and Social Challenge, 1989: 353.
   Google Scholar
• Just G, Laubenberger C, Helm EB, Falk S, Stille L. Clinical course and treatment of cryptococcal meningitis in AIDS patients. 16th Int Congr Chemother 1989, (Abstract).
   Google Scholar
• Baley JE, Kliegman RM, Fanaroff AA. Disseminated fungal infections in very low birthweight infants: therapeutic toxicity. Pediatrics 1984; 73 (2): 153–157.
   Google Scholar
• Bottineau MC, Roze JC, Mouzard A. Candidoses néon-atales systémiques. Ann Ped 1988; 35 (4): 235–243.
   Google Scholar
• Armstrong D. Problems in the treatment of opportunistic fungal infections. In: Holmberg K and Mayer RD (ed): Diagnosis and Therapy of Systemic Fungal Infections. New York: Raven Press. 1989: 149–158.
   Google Scholar
• V Eiff M, Essink M, Roos N, Hiddermann W, Buechner Th, van de Loo J. Hepatosplenic candidosis. Zeitschr Antimikrob Antineoplast Chemother 1989; Suppl 1: 1.
   Google Scholar
• Haron E, Feld R, Tuffnell P, Patterson B, Hasselback R, Matlow A. Hepatic candidiasis: an increasing problem in immunocompromised patients. Am J Med. 1987; 83: 17–26.
   Google Scholar
• Thaler M, Pastakia B, Shawker TH, O'Leary T, Pizzo PA. Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Ann Int Med 1988; 108 (1): 88–100.
   Google Scholar
• Cheng IKP, Fang GX, Chan TM, Chan PCK, Chan MK. Fungal peritonitis complicating peritoneal dialysis: report of 27 cases and review of treatment. Quart J Med, New Series 71, 1989; 265: 407–416.
   Google Scholar
• Slingeneyer A, Laroche B, Stec F, Canaud B, Beraud JJ, Mion C. Oral ketoconazole plus intraperitoneal 5-fluorocy-tosine as the sole treatment of fungal peritonitis (abstract). Perit Dial Bull 1984; 4 (Suppl): S60.
   Google Scholar
• Dupont B, Drouhet E. Cutaneous, ocular, and osteoarticular candidiasis in heroin addicts: new clinical and therapeutic aspects in 38 patients. J Inf Dis 1985; 152: 577–591.
   Google Scholar
• Walsh T, Pizzo PA. Fungal infections in granulocyto-penic patients: current approaches to classification, diagnosis and treatment. In: Holmberg K and Meyer RD (ed): Diagnosis and Therapy of Systemic Fungal Infections. New York: Raven Press. 1989: 47–70.
   Google Scholar
• Burch PA, Karp JE, Mery WG et al. Favorable outcome of invasive aspergillosis in patients with acute leukemia. J Clin Oncol 1987; 5: 1985–1993.
   Google Scholar
• Bodey GP, Vartivarian S. Aspergillosis. Eur J Clin Microbiol Infect Dis 1989; 8 (5): 413–437.
   Google Scholar
• Denning DW, Tucker RM, Hanson LH, Stevens DA. Treatment of invasive aspergillosis with itraconazole. Am J Med 1989; 86: 791–800.
   Google Scholar
• Viviani M, Tortorano AM. Management of cryptococcosis in AIDS patients. 10th Congr Int Soc Human Animal Mycol ISHAM 1988; (poster presentation).
   Google Scholar
• Borelli D. A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis. Rev Infect Dis 1987; 9 Suppl 1: S57.
   Google Scholar
• Atukorala DN, Pothupitiya GM. Treatment of chormomycosis with a combination of ketoconazole and 5-fluorocytosine. Ceylon Med J 1985; 30 (4): 193–195.
   Google Scholar
• Moulin G, Cognat Th, Ferrier E, AUigier H. Chromomycose: efficacité de l'association itraconazole + 5-fluorocytosine. J Dermatol de Paris 1989; 14: 54.
   Google Scholar